CA Patent

CA3160484A1 — Ophthalmic pharmaceutical compositions

Assigned to Vanda Pharmaceuticals Inc · Expires 2021-06-10 · 5y expired

What this patent protects

The present invention provides ophthalmic pharmaceutical compositions of the compound of Formula (I).

USPTO Abstract

The present invention provides ophthalmic pharmaceutical compositions of the compound of Formula (I).

Drugs covered by this patent

Unithroid (LEVOTHYROXINE SODIUM) · Fresenius Kabi

Patent Metadata

Patent number: CA3160484A1
Jurisdiction: CA
Classification: —
Expires: 2021-06-10
Drug substance claim: No
Drug product claim: No
Assignee: Vanda Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.